Martínez, Silvina Natalini, et al. “Safety and Immunogenicity of a PHH-1V Booster Dose After Different Prime Vaccination Schemes Against Covid-19: Phase III Clinical Trial Final Results Up To One Year”. Archives of Clinical and Biomedical Research, vol. 8, no. 4, Aug. 2024, pp. 326-42, https://fortunejournals.org/ojs/index.php/acbr/article/view/15082.